Axsome Therapeutics (AXSM) Depreciation and Depletion (2015 - 2026)
Axsome Therapeutics recorded quarterly Depreciation and Depletion of $116000.0 in Q1 2026, up 1.75% quarter-over-quarter from $114000.0 in Q4 2025, and down 22.15% year-over-year from $149000.0 in Q1 2025.
Axsome Therapeutics' Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $116000.0 for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 22.15% year-over-year to $116000.0; the TTM figure through Mar 2026 stood at $470000.0 (down 14.39% YoY), while the FY2025 annual figure was $503000.0, down 5.45% from the prior year.
- Depreciation and Depletion came in at $116000.0 for Q1 2026 at Axsome Therapeutics, up from $114000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $149000.0 in Q1 2025 to a low of $37000.0 in Q1 2022.
- A 5-year average of $110176.5 and a median of $120000.0 in 2025 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 587.25% in 2022 and fell 22.15% in 2026, its largest moves.
- Axsome Therapeutics' Depreciation and Depletion stood at $85000.0 in 2022, then jumped by 56.47% to $133000.0 in 2023, then fell by 3.01% to $129000.0 in 2024, then declined by 11.63% to $114000.0 in 2025, then gained by 1.75% to $116000.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $116000.0, $114000.0, and $120000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 116,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 129,000.00 |
| Dec 31, 2024 | 129,000.00 |
| Sep 30, 2024 | 131,000.00 |
| Sep 30, 2024 | 131,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 136,000.00 |
| Sep 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Sep 30, 2022 | 74,000.00 |
| Sep 30, 2022 | 74,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 30,695.00 |
| Dec 31, 2021 | 30,695.00 |
| Sep 30, 2021 | 27,230.00 |
| Sep 30, 2021 | 27,230.00 |
| Jun 30, 2021 | 9,749.00 |
| Jun 30, 2021 | 9,749.00 |
| Mar 31, 2021 | 8,326.00 |
| Mar 31, 2021 | 8,326.00 |
| Dec 31, 2020 | 7,382.00 |
| Dec 31, 2020 | 7,382.00 |
| Sep 30, 2020 | 5,522.00 |
| Sep 30, 2020 | 5,522.00 |
| Jun 30, 2020 | 5,524.00 |
| Jun 30, 2020 | 5,524.00 |
| Mar 31, 2020 | 5,436.00 |
| Mar 31, 2020 | 5,436.00 |
| Dec 31, 2019 | 5,392.00 |
| Dec 31, 2019 | 5,392.00 |
| Sep 30, 2019 | 9,389.00 |
| Sep 30, 2019 | 9,389.00 |
| Jun 30, 2019 | 11,110.00 |
| Jun 30, 2019 | 11,110.00 |
| Mar 31, 2019 | 11,439.00 |
| Mar 31, 2019 | 11,439.00 |
| Dec 31, 2018 | 12,207.00 |
| Dec 31, 2018 | 12,207.00 |
| Sep 30, 2018 | 13,077.00 |
| Sep 30, 2018 | 13,077.00 |
| Jun 30, 2018 | 11,713.00 |
| Jun 30, 2018 | 11,713.00 |
| Mar 31, 2018 | 11,938.00 |
| Mar 31, 2018 | 11,938.00 |
| Dec 31, 2017 | 11,274.00 |
| Dec 31, 2017 | 11,274.00 |
| Sep 30, 2017 | 10,783.00 |
| Sep 30, 2017 | 10,783.00 |
| Jun 30, 2017 | 10,387.00 |
| Jun 30, 2017 | 10,387.00 |
| Mar 31, 2017 | 10,113.00 |
| Mar 31, 2017 | 10,113.00 |
| Dec 31, 2016 | 9,751.00 |
| Dec 31, 2016 | 9,751.00 |
| Sep 30, 2016 | 5,618.00 |
| Sep 30, 2016 | 5,618.00 |
| Jun 30, 2016 | 3,003.00 |
| Jun 30, 2016 | 3,003.00 |
| Mar 31, 2016 | 2,112.00 |
| Mar 31, 2016 | 2,112.00 |
| Dec 31, 2015 | 1,251.00 |
| Dec 31, 2015 | 1,251.00 |
| Sep 30, 2015 | 1,122.00 |
| Sep 30, 2015 | 1,122.00 |
| Jun 30, 2015 | 865.00 |
| Jun 30, 2015 | 865.00 |
| Mar 31, 2015 | 304.00 |
| Mar 31, 2015 | 304.00 |